Home > PB Ratio > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
PB (Price/Book ) Ratio

The Current P/B Ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 20.20.

Share Price ₹2,078.0May 06,2024
Market Cap ₹35,200.5 Cr
Book Value₹1,743.0 CrMar2023 - Consolidated Results
Price/Book 20.20xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks

Definition & Calculation of PB (Price/Book ) ratio of GLAXOSMITHKLINE PHARMACEUTICALS

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of GLAXOSMITHKLINE PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹35,200.5 Cr] as on May 06,2024

(/) Book Value [ ₹1,743.0 Cr] based on Mar2023 - Consolidated Results

(=) P/B Ratio [ 20.20x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for GLAXOSMITHKLINE PHARMACEUTICALS , the investors are currently willing to pay '20.20 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of GLAXOSMITHKLINE PHARMACEUTICALS !

The chart below summarizes the trend in P/B Ratio of GLAXOSMITHKLINE PHARMACEUTICALS over the last five years.

Historical PB (Price/Book ) ratio chart of GLAXOSMITHKLINE PHARMACEUTICALS


PB Ratio Performance Analysis for GLAXOSMITHKLINE PHARMACEUTICALS

- GLAXOSMITHKLINE PHARMACEUTICALS 's latest p/b ratio is 20.20x.

- GLAXOSMITHKLINE PHARMACEUTICALS 's p/b ratio for fiscal years ending Mar2023 to Mar2019 averaged 12.37x.

- GLAXOSMITHKLINE PHARMACEUTICALS 's operated at median p/b ratio of 11.59x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, GLAXOSMITHKLINE PHARMACEUTICALS 's p/b ratio peaked in Mar2021 at 16.51x.

- GLAXOSMITHKLINE PHARMACEUTICALS 's p/b ratio hit its five-year low in Mar2019 of 10.29x.


How does GLAXOSMITHKLINE PHARMACEUTICALS 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
GLAXOSMITHKLINE PHARMACEUTICALS 1,742.9520.2035,200.5
SUN PHARMACEUTICAL INDUSTRIES LTD55,995.406.55367,026.0
CIPLA LTD23,346.004.92114,925.0
DR REDDYS LABORATORIES LTD23,140.404.54105,109.0
ZYDUS LIFESCIENCES LTD17,515.805.87102,736.0
DIVIS LABORATORIES LTD12,767.108.23105,128.0
MANKIND PHARMA LTD7,435.1612.3191,490.4
TORRENT PHARMACEUTICALS LTD6,198.0714.8391,906.5
LUPIN LTD12,315.606.2276,554.6
AUROBINDO PHARMA LTD26,839.802.5468,144.7
ABBOTT INDIA LTD3,146.0217.4054,743.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs GLAXOSMITHKLINE PHARMACEUTICALS 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 2.54x
Max industry PB 20.20x
Median industry PB 6.55x
Average industry PB 9.42x



You may also like the below Video Courses